Smith-Lemli-Opitz syndrome (SLOS, RSH/SLO syndrome, MIM 270400) is an autos
omal recessive multiple malformation/mental retardation syndrome initially
described by Smith et al. [1964] that is due to a defect in cholesterol bio
synthesis. The behavioral phenotype of Smith-Lemli-Opitz syndrome demonstra
tes cognitive abilities from borderline intellectual functioning to profoun
d mental retardation, sensory hyperreactivity, irritability, language impai
rment, sleep cycle disturbance, self-injurious behavior, and autism spectru
m behaviors. In a recent study of 28 subjects, 14 subjects (50%) with SLOS
also exhibited the behavior of throwing themselves backward in a characteri
stic upper body movement ("opisthokinesis") and 2 adolescents had a stretch
ing motion of the upper body accompanied by hand flicking [Tierney et al.,
1999]. In that same study, 6 of 13 subjects (46%) met the Autism Diagnostic
Interview-Revised (ADI-R) algorithm criteria (Lord et al. [1993] infant Me
ntal Health 14:234-252; Lord et al. [1994] J Autism Dev Disord 24:659-685)
and the Diagnostic and Statistical Manual (APA [1994] DSM-IV) diagnostic cr
iteria for autistic disorder. Smith-Lemli-Opitz syndrome is a metabolic dis
order that is associated with autism. (C) 2000 Wiley-Liss, Inc.